Rm. Poses et al., CONTROLLING FOR CONFOUNDING BY INDICATION FOR TREATMENT - ARE ADMINISTRATIVE DATA EQUIVALENT TO CLINICAL-DATA, Medical care, 33(4), 1995, pp. 36-46
There has been controversy about whether confounding by indication for
treatment-that is, owing to physicians' conscious efforts to base tre
atment decisions on patients' pretreatment prognoses-makes nonrandomiz
ed, observational comparisons of treatments invalid. Some now believe
evidence from studies of practice variation means that physicians' tre
atment decisions have little relationship to patients' prognostic clin
ical characteristics. They therefore believe that patients who receive
different treatments should vary little in their baseline prognoses,
and multivariable statistical methods should easily be able to adjust
for any resultant confounding, even when analyses are restricted to ad
ministrative rather than clinical data. The objective of this study is
to determine whether adjusting for variables found in administrative
data sets produces the same results as does adjusting for clinical var
iables. Data were reanalyzed from a previously enrolled prospective se
quential cohort of 227 hospitalized patients with suspected bacteremia
who had blood cultures. The treatment under study was aminoglycoside
therapy given empirically, that is, before blood culture results were
known. The outcome of interest was death during hospitalization. Univa
riable analyses suggest that empiric aminoglycoside therapy had a posi
tive association with mortality, by univariable logistic regression, o
dds ratio (OR) = 3.1 (95% confidence interval = [1.6, 5.8]). Few admin
istrative variables had univariable associations with aminoglycoside u
se or death. Multivariable analyses that controlled for them still sug
gest that aminoglycosides increased mortality; for example, in one mod
el, adjusted OR = 3.2 (1.6, 6.5). Many clinical variables were strongl
y associated with aminoglycoside use or death. Analyses that controlle
d for them suggested that empiric aminoglycosides did not increase mor
tality; for example, in one model, adjusted OR = 1.2 (0.55, 2.7.) Resu
lts of adjustment for confounding using administrative data disagreed
with the results of adjustment using clinical data. It is concluded th
at nonrandomized, observational outcome studies that fail to control f
or prognostic differences between patients receiving different treatme
nts may not always be valid.